[13C,2H5]-Cabotegravir

Catalog Number	ACMA00065223
Description	Cabotegravir is intended for Pharmaceuticals applications. Cabotegravir is a long acting HIV-1 integrase inhibitor with action against a broad range of HIV subtypes. All information about [13C,2H5]-Cabotegravir is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis.
Synonyms	GSK-1265744-13C-d5, S-265744-13C-d5, (3S,11aR)-N-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-, (3S,11aR)Oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide-13C-d5
Molecular Weight	411.38
Molecular Formula	C19H17F2N3O5
Purity	≥95%
Isotopic Enrichment	99% 13C, 98% 2H
Stability	≥1 year
Unlabeled CAS	1051375-10-0

Please kindly note that our products and services are for research use only.

Online Inquiry



mg g kg ml L

[13C,2H5]-Cabotegravir (ACMA00065223)

SUBMIT